Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 9 filers reported holding Astellas Pharma Inc in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,960,617 | -2.8% | 199,100 | -7.2% | 0.07% | -6.8% |
| Q1 2023 | $3,044,828 | -3.4% | 214,500 | +6.0% | 0.07% | +7.2% |
| Q1 2022 | $3,153,000 | +0.2% | 202,400 | +4.6% | 0.07% | +1.5% |
| Q4 2021 | $3,148,000 | +15.2% | 193,500 | +17.0% | 0.07% | +7.9% |
| Q3 2021 | $2,732,000 | -7.3% | 165,400 | -20.2% | 0.06% | -22.2% |
| Q2 2019 | $2,948,000 | -49.9% | 207,330 | -55.3% | 0.08% | -49.1% |
| Q4 2017 | $5,886,000 | -3.2% | 464,123 | -3.2% | 0.16% | -5.4% |
| Q3 2017 | $6,081,000 | -38.9% | 479,559 | -41.1% | 0.17% | -40.8% |
| Q2 2017 | $9,955,000 | -7.2% | 813,965 | -0.1% | 0.28% | -8.1% |
| Q1 2017 | $10,731,000 | -5.3% | 814,454 | -0.3% | 0.31% | -9.1% |
| Q4 2016 | $11,326,000 | -24.7% | 817,110 | -15.2% | 0.34% | -25.3% |
| Q3 2016 | $15,048,000 | – | 963,505 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RENAISSANCE GROUP LLC | 391,745 | $5,438,880 | 0.25% |
| Cassady Schiller Wealth Management, LLC | 698 | $9,667 | 0.01% |
| MAI Capital Management | 19,087 | $264,362 | 0.00% |
| SVB WEALTH LLC | 10,472 | $145,037 | 0.00% |
| RHUMBLINE ADVISERS | 34,759 | $481,408 | 0.00% |
| First Horizon Advisors, Inc. | 114 | $1,578 | 0.00% |
| Operose Advisors LLC | 90 | $1,247 | 0.00% |
| Russell Investments Group, Ltd. | 783 | $10,845 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 166 | $2,299 | 0.00% |